Refractory Tophaceous Gout With Psoriatic Arthritis: A Case Report
Author Information
Author(s): Muacevic Alexander, Adler John R, Coelho Rui, Silva Isabel Fonseca, Xavier Pires Sara, Fonseca Tomás
Primary Institution: Unidade Local de Saúde de Santo António, Porto, PRT
Hypothesis
Can IL-1-blocking therapy effectively control refractory tophaceous gout overlapping with psoriatic arthritis?
Conclusion
The introduction of IL-1-blocking therapy was crucial for controlling the patient's refractory gout and achieving disease remission.
Supporting Evidence
- The patient had a long history of untreated hyperuricemia and tophaceous gout.
- Control of the disease was only achieved after the introduction of IL-1-blocking therapy.
- The patient experienced significant comorbidities, including psoriatic arthritis.
Takeaway
This study is about a man with a very bad case of gout that didn't get better with regular medicine, but he finally felt better after getting a special treatment that helps reduce inflammation.
Methodology
The case study details the patient's history, treatment progression, and outcomes over time.
Limitations
The study is based on a single case, limiting the generalizability of the findings.
Participant Demographics
A 63-year-old man with a history of untreated hyperuricemia and multiple comorbidities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website